Hypoxia activates the IGF-1 expression through STAT5b in human HepG2 cells

Biochemical and Biophysical Research Communications

Volumn 358, Issue 3, 2007, Pages 733-738

  Joung, Youn Hee ^a   Lee, Moon Young ^a   Lim, Eun Joung ^a   Kim, Mi Sun ^a   Hwang, Tae Sook ^a   Kim, Sang Yoon ^a   Ye, Sang Kyu ^b   Lee, Jae Dong ^c   Park, Taekyu ^d   Woo, Young Sam ^e   Chung, Ill Min ^f   Yang, Young Mok ^a  

^a Bio Food and Drug Research Center   (South Korea)

^b Seoul National University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Konkuk University Glocal Campus   (South Korea)

^e Konkuk F and B Co Ltd   (South Korea)

^f Konkuk University   (South Korea)

Author keywords

Binding site; Gene expression; HepG2; Hypoxia; IGF 1; Solid tumor cell; STAT5b

Indexed keywords

NUCLEAR PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN C; STAT5B PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANOXIA; BINDING SITES; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OXYGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAT5 TRANSCRIPTION FACTOR;

EID: 34249295949     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.201     Document Type: Article

References (29)

1. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
2. Bando H., Toi M., Kitada K., and Koike M. Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomed. Pharmacother. 57 (2003) 333-340
3. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
4. Duan C. Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. J. Endocrinol. 175 (2002) 41-54
5. Martin M.B., and Stoica A. Insulin-like growth factor-1 and estrogen interactions in breast cancer. J. Nutr. 132 (2002) 3799S-3801S
6. Daughaday W.H., and Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structure, serum and tissue concentrations. Endocr. Rev. 10 (1989) 68-91
7. Coskun U., Gunel N., Sancak B., Gunel U., Onuk E., Bayram O., Yilmaz E., Candan S., and Ozkan S. Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. Breast 12 (2003) 104-110
8. Sjogren K., Liu J.L., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Tornell J., Isaksson O.G., Jansson J.O., and Ohlsson C. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA 96 (1999) 7088-7092
9. Krajcik R.A., Borofsky N.D., Massardo S., and Orentreich N. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1566-1573
10. Mathews L.S., Norstedt G., and Palmiter R.D. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. USA 83 (1986) 9343-9347
11. Bichell D.P., Kikuchi K., and Rotwein P. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol. Endocrinol. 6 (1992) 1899-1908
12. Woelfle J., Chia D.J., and Rotwein P. Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J. Biol. Chem. 278 (2003) 51261-51266
13. Joung Y.H., Lim E.J., Lee M.Y., Park J.H., Ye S.K., Park E.U., Kim S.Y., Zhang Z., Lee K.J., Park D.K., Park T.K., Moon W.K., and Yang Y.M. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells. Exp. Mol. Med. 37 (2005) 353-364
14. Onishi M., Kinoshita S., Morikawa Y., Shibuty A., Phillips J., Lanier L.L., Gorman D.M., Nolan G.P., Miyajima A., and Kitamura T. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24 (1996) 324-329
15. Wang Y., and Jiang H. Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression. J. Biol. Chem. 280 (2005) 10955-10963
16. Joung Y.H., Park J.H., Park T., Lee C.S., Kim O.H., Ye S.K., Yang U.M., Lee K.J., and Yang Y.M. Hypoxia activated signal transducers and activators of transcription 5 (STAT5) and increase its binding activity to the GAS element in mammary epithelial cells. Exp. Mol. Med. 35 (2003) 350-357
17. Huang A., Zang Y.Y., Chen K., Hatakeyama K., and Keaney Jr. JF. Cytokine-stimulated GTP cyclohydrolase 1 expression in endothelial cells requires coordinated activation of nuclear factor-κB and Stat1/Stat3. Circ. Res. 96 (2005) 164-171
18. Macaulay V.M. Insulin-like growth factors and cancer. Br. J. Cancer 65 (1992) 311-320
19. Yi H.K., Hwang P.H., Yang D.H., Kang C.W., and Lee D.Y. Expression of insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur. J. Cancer 37 (2001) 2257-2263
20. Hwang P.H., Kim S.Y., Lee J.C., Kim S.J., Yi H.K., and Lee D.Y. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells. Exp. Mol. Med. 37 (2005) 391-398
21. Hwa V., Little B., Kofoed E.M., and Rosenfeld R.G. Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b. J. Biol. Chem. 279 (2004) 2728-2736
22. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram R.A., Waxman D.J., and Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94 (1997) 7239-7244
23. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., and Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 (1998) 841-850
24. Davey H.W., Xie T., McLachlan M.J., Wilkins R.J., Waxman D.J., and Grattan D.R. STAT5b is required for GH-induced liver IGF-1 gene expression. Endocrinology 142 (2001) 3836-3842
25. Woelfle J., Billiard J., and Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J. Biol. Chem. 278 (2003) 22696-22702
26. Ariyoshi K., Nosaka T., Yamada K., Onishi M., Oka Y., Miyajima A., and Kitamura T. Constitutive activation of STAT5 by a point mutation in the SH2 domain. J. Biol. Chem. 275 (2000) 24407-24413
27. Park J.H., Lee H.Y., Roh S.C., Kim H.Y., and Yang Y.M. Screening of differentially expressed genes by desferrioxamine or ferric ammonium citrate treatment in HepG2 Cells. J. Biochem. Mol. Biol. 33 (2000) 396-401
28. Park J.H., Park T.K., Kim H.Y., and Yang Y.M. The IGFBP-1 mRNA expression in HepG2 cells is affected by inhibition of heme biosynthesis. J. Biochem. Mol. Biol. 34 (2001) 385-389
29. Lee M.Y., Joung Y.H., Lim E.J., Lee M.Y., Park J.H., Ye S.K., Park T.K., Zhang Z., Park D.K., Lee K.J., and Yang Y.M. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 15 (2006) 187-195